PENPACT-@ had a @ @ factorial design , randomizing HIV-infected children to start protease inhibitor ( PI ) versus nonnucleoside reverse transcriptase inhibitor ( NNRTI ) - based ART , and switch at a @ copies/mL versus @,@ copies/mL threshold .